2 Cash-Producing Stocks to Research Further and 1 We Find Risky

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.

Cash flow is valuable, but it’s not everything - StockStory helps you identify the companies that truly put it to work. Keeping that in mind, here are two cash-producing companies that leverage their financial strength to beat the competition and one best left off your watchlist.

One Stock to Sell:

EverQuote (EVER)

Trailing 12-Month Free Cash Flow Margin: 13%

Aiming to simplify a once complicated process, EverQuote (NASDAQ:EVER) is an online insurance marketplace where consumers can compare and purchase various types of insurance from different providers

Why Does EVER Give Us Pause?

1. Excessive marketing spend signals little organic demand and traction for its platform

EverQuote’s stock price of $26.14 implies a valuation ratio of 8x forward EV/EBITDA. To fully understand why you should be careful with EVER, check out our full research report (it’s free).

Two Stocks to Watch:

Lennox (LII)

Trailing 12-Month Free Cash Flow Margin: 10%

Based in Texas and founded over a century ago, Lennox (NYSE:LII) is a climate control solutions company offering heating, ventilation, air conditioning, and refrigeration (HVACR) goods.

Why Do We Like LII?

1. Excellent operating margin of 17.2% highlights the efficiency of its business model, and it turbocharged its profits by achieving some fixed cost leverage
2. Performance over the past two years was turbocharged by share buybacks, which enabled its earnings per share to grow faster than its revenue
3. Market-beating returns on capital illustrate that management has a knack for investing in profitable ventures

At $532.75 per share, Lennox trades at 22.6x forward P/E. Is now the right time to buy? See for yourself in our full research report, it’s free.

Tenet Healthcare (THC)

Trailing 12-Month Free Cash Flow Margin: 7.2%

With a network spanning nine states and serving primarily urban and suburban communities, Tenet Healthcare (NYSE:THC) operates a nationwide network of hospitals, ambulatory surgery centers, and outpatient facilities providing acute care and specialty healthcare services.

Why Are We Positive On THC?

1. Performance over the past five years was turbocharged by share buybacks, which enabled its earnings per share to grow faster than its revenue
2. Industry-leading 22.1% return on capital demonstrates management’s skill in finding high-return investments, and its rising returns show it’s making even more lucrative bets
3. Improving returns on capital reflect management’s ability to monetize investments

Tenet Healthcare is trading at $199.56 per share, or 12.4x forward P/E. Is now a good time to buy? Find out in our full research report, it’s free.

Stocks We Like Even More

If your portfolio success hinges on just 4 stocks, your wealth is built on fragile ground. You have a small window to secure high-quality assets before the market widens and these prices disappear.

Don’t wait for the next volatility shock. Check out our Top 6 Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.